81 FR 32754 - Advisory Committee on Immunization Practices (ACIP)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 100 (May 24, 2016)

Page Range		32754-32755
FR Document		2016-12150

Federal Register, Volume 81 Issue 100 (Tuesday, May 24, 2016)

[Federal Register Volume 81, Number 100 (Tuesday, May 24, 2016)]
[Notices]
[Pages 32754-32755]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-12150]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee.

Time and Date

8:00 a.m.-6:00 p.m., EDT, June 22, 2016
8:00 a.m.-5:00 p.m., EDT, June 23, 2016

    Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton 
Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia 
30329.
    Status: Open to the public, limited only by the space available. 
Time will be available for public comment. The public is welcome to 
submit written comments in advance of the meeting. Comments should be 
submitted in writing by email to the contact person listed below. The 
deadline for receipt June 13, 2016. All requests must contain the name, 
address, and organizational affiliation of the speaker, as well as the 
topic being addressed. Written comments should not exceed one single-
spaced typed page in length and delivered in 3 minutes or less. Please 
note that the public comment period may end before the time indicated, 
following the last call for comments. Members of the public who wish to 
provide public comments should plan to attend the public comment 
session at the start time listed. Written comments received in advance 
of the meeting will be included in the official record of the meeting.
    The meeting will be webcast live via the World Wide Web; for 
instructions and more information on ACIP please visit the ACIP Web 
site: http://www.cdc.gov/vaccines/acip/index.html.
    Purpose: The committee is charged with advising the Director, CDC, 
on the appropriate use of immunizing agents. In addition, under 42 
U.S.C. 1396s, the committee is mandated to establish and periodically 
review and, as appropriate, revise the list of vaccines for 
administration to vaccine-eligible children through the Vaccines for 
Children (VFC) program, along with schedules regarding the appropriate 
periodicity, dosage, and contraindications applicable to the vaccines. 
Further, under provisions of the Affordable Care Act, at section 2713 
of the Public Health Service Act, immunization recommendations of the 
ACIP that have been adopted by the Director of the Centers for Disease 
Control and Prevention and appear on the CDC immunization schedules 
must be covered by applicable health plans.
    Matters for Discussion: The agenda will include discussions on: 
Meningococcal vaccines; human papillomavirus vaccines; influenza; 
cholera vaccine; hepatitis vaccines; safety of maternal Tdap 
vaccination; child/adolescent immunization schedule; Respiratory 
Syncytial Virus (RSV) and vaccine supply. A recommendation vote is 
scheduled for meningococcal vaccines and cholera vaccine. A Vaccines 
for Children (VFC) vote is scheduled for meningococcal vaccines.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Stephanie Thomas, National 
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton 
Road, NE., MS-A27, Atlanta, Georgia 30329, telephone 404/639-8836; 
Email [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of

[[Page 32755]]

meetings and other committee management activities for both the Centers 
for Disease Control and Prevention and the Agency for Toxic Substances 
and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2016-12150 Filed 5-23-16; 8:45 am]
 BILLING CODE 4160-18-P

Federal Register / Vol. 81, No. 100 / Tuesday, May 24, 2016 / Notices 32755

meetings and other committee 552b(c)(4) and (6), Title 5 U.S.C., and the collection of information on those
management activities for both the the Determination of the Director, who are to respond, including through
Centers for Disease Control and Management Analysis and Services the use of appropriate automated,
Prevention and the Agency for Toxic Office, Centers for Disease Control and electronic, mechanical, or other
Substances and Disease Registry. Prevention, pursuant to Section 10(d) technological collection techniques or
Pub. L. 92–463. Agenda items are other forms of information technology,
Elaine L. Baker,
subject to change as priorities dictate. e.g., permitting electronic submission of
Director, Management Analysis and Services Person for More Information: Price responses; and (e) Assess information
Office, Centers for Disease Control and
Connor, Ph.D., NIOSH Health Scientist, collection costs.
Prevention.
CDC, 2400 Executive Parkway, Mailstop To request additional information on
[FR Doc. 2016–12150 Filed 5–23–16; 8:45 am] the proposed project or to obtain a copy
E–20, Atlanta, Georgia 30345,
BILLING CODE 4160–18–P
Telephone: 404–498–2511, Fax: 404– of the information collection plan and
498–2571. instruments, call (404) 639–7570 or
The Director, Management Analysis send an email to omb@cdc.gov. Written
DEPARTMENT OF HEALTH AND comments and/or suggestions regarding
HUMAN SERVICES and Services Office, has been delegated
the authority to sign Federal Register the items contained in this notice
notices pertaining to announcements of should be directed to the Attention:
Centers for Disease Control and
meetings and other committee CDC Desk Officer, Office of Management
Prevention
management activities for both the and Budget, Washington, DC 20503 or
Safety and Occupational Health Study Centers for Disease Control and by fax to (202) 395–5806. Written
Section (SOHSS), National Institute for Prevention and the Agency for Toxic comments should be received within 30
Occupational Safety and Health Substances and Disease Registry. days of this notice.
(NIOSH or Institute) Proposed Project
Elaine L. Baker,
In accordance with section 10(a)(2) of Director, Management Analysis and Services Ingress/Egress and Work Boot Outsole
the Federal Advisory Committee Act (P. Office Centers for Disease Control and Wear Investigation at Surface Mines—
L. 92–463), the Centers for Disease Prevention. New—National Institute for
Control and Prevention (CDC) [FR Doc. 2016–12225 Filed 5–23–16; 8:45 am] Occupational Safety and Health
announces the following committee BILLING CODE 4163–18–P (NIOSH), Centers for Disease Control
meeting. and Prevention (CDC).
Times and Dates: 8:00 a.m.–5:00 p.m.,
Background and Brief Description
EDT, June 14, 2016 (Closed); 8:00 a.m.– DEPARTMENT OF HEALTH AND
5:00 p.m., EDT, June 15, 2016 (Closed). HUMAN SERVICES The mission of the National Institute
Place: Embassy Suites, 1900 Diagonal for Occupational Safety and Health
Road, Alexandria, Virginia 22314, Centers for Disease Control and (NIOSH) is to promote safety & health at
Telephone: 703–684–5900, Fax: 703– Prevention work for all people through research
684–0653. and prevention. NIOSH, under PL 91–
[30Day–16–16GK]
Purpose: The Safety and Occupational 173 as amended by PL 95–164 (Federal
Health Study Section will review, Agency Forms Undergoing Paperwork Mine Safety and Health Act of 1977) has
discuss, and evaluate grant Reduction Act Review the responsibility to conduct research to
application(s) received in response to improve working conditions and to
the Institute’s standard grants review The Centers for Disease Control and prevent accidents and occupational
and funding cycles pertaining to Prevention (CDC) has submitted the diseases in the U.S. mining sector. The
research issues in occupational safety following information collection request goal of the proposed project is to
and health, and allied areas. to the Office of Management and Budget investigate how ingress/egress systems
It is the intent of NIOSH to support (OMB) for review and approval in on mobile equipment, and personal
broad-based research endeavors in accordance with the Paperwork protective footwear (boots) used by
keeping with the Institute’s program Reduction Act of 1995. The notice for miners may lead to slips, trips and falls
goals. This will lead to improved the proposed information collection is at stone, sand and gravel surface mining
understanding and appreciation for the published to obtain comments from the facilities. NIOSH is requesting a three-
magnitude of the aggregate health public and affected agencies. year approval for this data collection.
burden associated with occupational Written comments and suggestions The project objective will be achieved
injuries and illnesses, as well as to from the public and affected agencies through two studies. The first study
support more focused research projects, concerning the proposed collection of aims to: Identify elements of ingress/
which will lead to improvements in the information are encouraged. Your egress systems on haulage trucks and
delivery of occupational safety and comments should address any of the front end loaders that pose a risk of
health services, and the prevention of following: (a) Evaluate whether the slips, trips and falls (STFs) and could
work-related injury and illness. It is proposed collection of information is lead to STF related injuries; to
anticipated that research funded will necessary for the proper performance of determine worker behavior associated
promote these program goals. the functions of the agency, including with STF incidents; and to learn how
Matters for Dicussion: The meeting whether the information will have purchasing/maintenance decisions are
will convene to address matters related practical utility; (b) Evaluate the made for ingress/egress systems. In the
sradovich on DSK3TPTVN1PROD with NOTICES

to the conduct of Study Section accuracy of the agencies estimate of the surface mining industry, it is still
business and for the study section to burden of the proposed collection of unclear which component of the
consider safety and occupational health- information, including the validity of ingress/egress system poses the greatest
related grant applications. the methodology and assumptions used; risk for STF. Hence there is a need to
These portions of the meeting will be (c) Enhance the quality, utility, and understand where, how and why STF
closed to the public in accordance with clarity of the information to be incidents occur during ingress/egress on
provisions set forth in Section collected; (d) Minimize the burden of mobile equipment.

VerDate Sep<11>2014 17:24 May 23, 2016 Jkt 238001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\24MYN1.SGM 24MYN1

Document Created: 2016-05-24 05:21:57
Document Modified: 2016-05-24 05:21:57

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		81 FR 32754

81 FR 32754 - Advisory Committee on Immunization Practices (ACIP)

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 81, Issue 100 (May 24, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention